0
0

Biotechnology & Health Innovations

Introduction

The pattern "Biotechnology & Health Innovations" covers major verified advancements and breakthroughs in biotechnology and healthcare sectors, including vaccines, gene-editing technologies, diagnostic tools, and digital health innovations. This topic is frequently asked in exams like SSC CGL, IBPS PO, and RRB NTPC due to its relevance in public health, medical research, and scientific progress.

Pattern: Biotechnology & Health Innovations

Pattern

This pattern tests knowledge of important biotechnology developments, approved vaccines, gene-editing breakthroughs, and health-tech innovations along with their developers and years.

Key Concept:

Biotechnology involves using living organisms or biological systems to develop products that improve healthcare, agriculture, and the environment. Health innovations include vaccines, gene therapies, diagnostics, and AI-based medical technologies.

Important Points:

  • mRNA Vaccines = Vaccines using messenger RNA technology (e.g., COVID-19 vaccines) enabling rapid development and scalable manufacturing.
  • CRISPR Technology = A precise gene-editing tool used in research and approved gene therapies (e.g., sickle cell disease gene therapy approved in 2023 in the UK and USA).
  • DNA-based Vaccines = ZyCoV-D, developed by Zydus Cadila, became the world’s first DNA-based COVID-19 vaccine authorized in 2021.
  • AI in Healthcare = Artificial Intelligence is used for radiology screening, early disease detection, and digital diagnostics.

Related Topics:

  • Digital Personal Data Protection in Health Sector
  • Vaccine Development & Emergency Use Authorization (EUA)
  • Gene Therapy Approvals (Global Developments)

Step-by-Step Example

Question

Which Indian biotechnology company developed the world's first DNA-based COVID-19 vaccine, ZyCoV-D, authorized for emergency use in 2021?

Options:

  • A. Bharat Biotech
  • B. Serum Institute of India
  • C. Zydus Cadila
  • D. Panacea Biotec

Solution

  1. Step 1: Identify the vaccine type

    ZyCoV-D is known as the world's first DNA-based COVID-19 vaccine.

  2. Step 2: Recall the developer

    Zydus Cadila developed ZyCoV-D and received emergency use authorization in 2021.

  3. Step 3: Eliminate other options

    Bharat Biotech developed Covaxin (inactivated vaccine), Serum Institute manufactured Covishield (viral vector vaccine), Panacea Biotec is known for other vaccine products.

  4. Final Answer:

    Zydus Cadila → Option C

  5. Quick Check:

    ZyCoV-D = Zydus Cadila (2021) ✅

Quick Variations

This pattern may appear as questions on:

  • 1. COVID-19 vaccine technologies and developers
  • 2. CRISPR gene-editing approvals (e.g., sickle cell therapy approved in 2023)
  • 3. AI-based medical diagnostics used in India

Trick to Always Use

  • Remember key vaccine names with their developers and year of authorization.
  • CRISPR = Precise gene-editing technology (approved therapies began in 2023 globally).

Summary

Summary

  • Biotechnology advances include vaccines, gene editing, and AI diagnostics.
  • ZyCoV-D is the first DNA-based COVID-19 vaccine authorized in 2021.
  • CRISPR-based gene therapy approvals began globally in 2023.

Remember:
ZyCoV-D = DNA vaccine by Zydus Cadila (2021)

Practice

(1/5)
1. Which Indian biotechnology company developed Covaxin, India's first indigenous COVID-19 vaccine?
easy
A. Zydus Cadila
B. Serum Institute of India
C. Bharat Biotech
D. Panacea Biotec

Solution

  1. Step 1: Identify the vaccine

    Covaxin is India's first fully indigenous COVID-19 vaccine using inactivated virus technology.

  2. Step 2: Recall the developer

    Bharat Biotech developed Covaxin in collaboration with ICMR.

  3. Final Answer:

    Bharat Biotech → Option C

  4. Quick Check:

    Covaxin = Bharat Biotech ✅
Hint: Covaxin = Bharat Biotech (inactivated vaccine).
Common Mistakes: Confusing Covaxin with Covishield (Serum Institute) or ZyCoV-D (Zydus Cadila).
2. ZyCoV-D, authorized for emergency use in India in 2021, is based on which vaccine technology?
easy
A. mRNA technology
B. Protein subunit technology
C. DNA-based technology
D. Viral vector technology

Solution

  1. Step 1: Identify vaccine type

    ZyCoV-D is known globally as the first DNA-based COVID-19 vaccine.

  2. Step 2: Recall technology

    It uses plasmid DNA technology to generate immune response.

  3. Final Answer:

    DNA-based technology → Option C

  4. Quick Check:

    ZyCoV-D = DNA vaccine ✅
Hint: ZyCoV-D → D = DNA.
Common Mistakes: Confusing it with mRNA or viral vector vaccines.
3. Covovax, approved for emergency use in India in December 2021, uses which technology?
easy
A. Messenger RNA technology
B. Protein subunit technology
C. Inactivated virus technology
D. DNA plasmid technology

Solution

  1. Step 1: Understand vaccine category

    Protein subunit vaccines contain purified viral proteins.

  2. Step 2: Recall Covovax platform

    Covovax (manufactured by Serum Institute of India) is a protein subunit vaccine.

  3. Final Answer:

    Protein subunit technology → Option B

  4. Quick Check:

    Covovax = Protein subunit ✅
Hint: Covovax → Protein platform.
Common Mistakes: Confusing with mRNA or viral vector vaccines.
4. Artificial Intelligence in healthcare is widely used in India for which of the following?
easy
A. Manual record keeping
B. Radiology image analysis
C. Traditional vaccine storage
D. Paper-based prescriptions

Solution

  1. Step 1: Identify AI applications

    AI is widely used for analyzing medical images such as X-rays and MRIs.

  2. Step 2: Eliminate incorrect options

    AI is not used for manual record keeping, paper prescriptions, or traditional storage.

  3. Final Answer:

    Radiology image analysis → Option B

  4. Quick Check:

    AI in healthcare = Imaging & diagnostics ✅
Hint: AI → Imaging.
Common Mistakes: Choosing options unrelated to digital innovation.
5. Which gene-editing technology received global approval in 2023 for treating sickle cell disease?
medium
A. RNA interference
B. Zinc Finger Nucleases
C. CRISPR-Cas9
D. TALEN

Solution

  1. Step 1: Recall major biotech milestone

    In 2023, the UK and USA approved the first CRISPR-based gene therapy for sickle cell disease.

  2. Step 2: Identify technology

    The therapy was based on CRISPR-Cas9 gene-editing technology.

  3. Final Answer:

    CRISPR-Cas9 → Option C

  4. Quick Check:

    First CRISPR therapy approval = 2023 ✅
Hint: CRISPR = First approved gene-editing therapy (2023).
Common Mistakes: Confusing CRISPR with older gene-editing tools.

Mock Test

Ready for a challenge?

Take a 10-minute AI-powered test with 10 questions (Easy-Medium-Hard mix) and get instant SWOT analysis of your performance!

10 Questions
5 Minutes